Placebo effect.

It doesn’t always work for the better. This meta-analysis of placebo-controlled immune checkpoint inhibitor trials in the adjuvant setting establishes a grade 3-4 toxicity incidence rate of 18%...in the placebo arms. This puts into question how often adverse events are related to treatment versus the disease itself. | Rodrigo Chacón, JAMA 2018